On October 6, 2025, DarioHealth Corp. (NASDAQ: DRIO) announced a strategic collaboration with OneStep, a U.S. Food and Drug Administration‑listed platform that delivers clinical‑grade gait and mobility insights using only a smartphone. The companies signed a Memorandum of Understanding and are working toward a Master Services Agreement that is expected to be finalized in the coming weeks.
The partnership will embed OneStep’s smartphone‑based, motion‑analysis technology into DarioHealth’s digital health ecosystem, providing members with real‑time fall‑risk identification and education without the need for wearables, sensors or calibration. The integration will enable DarioHealth’s cardiometabolic and behavioral health programs to proactively address fall risk among high‑risk populations such as obese adults and Medicare Advantage members with frailty.
The U.S. fall‑management market, which includes digital assessment tools, monitoring systems and prevention programs, was valued at nearly $200 million in 2024 and is projected to grow to more than $300 million by 2033, a compound annual growth rate of over 5 %. By adding fall‑risk capabilities, DarioHealth expands its value proposition to health plans and self‑insured employers seeking to reduce costly fall‑related hospitalizations and improve Star measure performance.
The collaboration positions DarioHealth to capture a growing segment of the digital health market and enhances its multi‑condition platform with a new, high‑impact use case. The integration is expected to increase member engagement, improve clinical outcomes, and generate additional revenue streams for DarioHealth’s B2B2C and payer customers.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.